中国组织工程研究 ›› 2026, Vol. 30 ›› Issue (33): 8751-8760.doi: 10.12307/2026.481

• 组织构建实验造模 experimental modeling in tissue construction • 上一篇    下一篇

靶向抑制聚腺苷二磷酸核糖聚合酶1减弱中性粒细胞介导的小鼠急性肺损伤

苏  彤,王  蒙,吕艳芳,许肖迪,仲伟祥,高婉君,高  歌,韩露露   

  1. 徐州医科大学,江苏省徐州市   221004
  • 收稿日期:2025-11-13 修回日期:2026-03-20 出版日期:2026-11-28 发布日期:2026-06-16
  • 通讯作者: 高歌,副教授,徐州医科大学,江苏省徐州市 221004 通讯作者:韩露露,讲师,徐州医科大学,江苏省徐州市 221004
  • 作者简介:苏彤,女,1993年生,安徽省宿州市人,汉族,硕士,助理实验师,主要从事中性粒细胞和急性肺损伤方面的研究。
  • 基金资助:
    国家自然科学基金青年科学基金项目(82203172),项目负责人:韩露露;2024年省科协青年科技人才托举工程项目(KY13062501),项目负责人:高歌;2024年校级青年科技创新团队(KY14012403),项目负责人:高歌;2024年徐医杰出青年人才高峰计划(RC5062503),项目负责人:高歌

Targeted inhibition of poly(ADP-ribose) polymerase 1 attenuates neutrophil-mediated acute lung injury in mice

Su Tong, Wang Meng, Lyu Yanfang, Xu Xiaodi, Zhong Weixiang, Gao Wanjun, Gao Ge, Han Lulu   

  1. Xuzhou Medical University, Xuzhou 221004, Jiangsu Province, China
  • Received:2025-11-13 Revised:2026-03-20 Online:2026-11-28 Published:2026-06-16
  • Contact: Gao Ge, Associate professor, Xuzhou Medical University, Xuzhou 221004, Jiangsu Province, China Co-corresponding author: Han Lulu, Lecturer, Xuzhou Medical University, Xuzhou 221004, Jiangsu Province, China
  • About author:Su Tong, MS, Assistant experimentalist, Xuzhou Medical University, Xuzhou 221004, Jiangsu Province, China
  • Supported by:
    National Natural Science Foundation of China (Youth Science Fund), No. 82203172 (to HLL); 2024 Provincial Association for Science and Technology Young Science and Technology Talent Support Project, No. KY13062501 (to GG); 2024 University-level Young Science and Technology Innovation Team, No. KY14012403 (to GG); 2024 Xuzhou Medical University Outstanding Young Talent Peak Plan, No. RC5062503 (to GG) 

摘要:



文题释义:
急性肺损伤:是一种严重的呼吸系统疾病,可由多种因素引发,如机械损伤、严重感染(脓毒症)、输血等,表现为肺泡上皮细胞和血管内皮细胞损伤、中性粒细胞大量浸润、弥漫性肺间质及肺泡水肿,进而导致急性呼吸功能不全,严重者可发展为急性呼吸窘迫综合征。
聚腺苷二磷酸核糖聚合酶1:是第一个被鉴定的聚腺苷二磷酸核糖聚合酶家族分子,是一种DNA修复酶,由DNA结合域、自修饰域和催化域组成,参与DNA损伤修复、蛋白质翻译后修饰和细胞凋亡等过程。研究表明,聚腺苷二磷酸核糖聚合酶1在调节和维持组织炎症中起着至关重要的作用。

背景:在急性肺损伤中,中性粒细胞的活化和组织浸润是重要参与因素之一,抑制聚腺苷二磷酸核糖聚合酶1活性可减少脂多糖处理后肺组织中浸润的中性粒细胞,缓解肺损伤。但聚腺苷二磷酸核糖聚合酶1调控中性粒细胞活化及功能的具体机制尚未完全阐明。
目的:探讨聚腺苷二磷酸核糖聚合酶1调控中性粒细胞活化对小鼠急性肺损伤的影响及作用机制。
方法:①以人早幼粒白血病细胞系HL-60 为基础,利用二甲基亚砜诱导其分化为中性粒细胞样细胞dHL-60,采用脂多糖刺激dHL-60,获得活化的中性粒细胞,Western blot检测活化的中性粒细胞中聚腺苷二磷酸核糖聚合酶1表达;②利用靶向人聚腺苷二磷酸核糖聚合酶1的shRNA制备聚腺苷二磷酸核糖聚合酶1低表达的中性粒细胞系,采用Western blot检测聚腺苷二磷酸核糖聚合酶1敲低效果;③通过Western blot、免疫荧光实验检测聚腺苷二磷酸核糖聚合酶1低表达对中性粒细胞极化的影响,细胞迁移实验检测聚腺苷二磷酸核糖聚合酶1低表达对中性粒细胞迁移的影响,实时荧光定量PCR和流式细胞术检测聚腺苷二磷酸核糖聚合酶1低表达对中性粒细胞趋化因子受体表达的影响,通过活性氧、白细胞介素1β和中性粒细胞胞外诱捕网评估聚腺苷二磷酸核糖聚合酶1低表达对中性粒细胞活性的影响;④利用靶向鼠聚腺苷二磷酸核糖聚合酶1的shRNA制备聚腺苷二磷酸核糖聚合酶1低表达的小鼠原代中性粒细胞,制备小鼠中性粒细胞过继转移模型,通过肺水肿、髓过氧化物酶活性和苏木精-伊红染色,验证聚腺苷二磷酸核糖聚合酶1低表达对脂多糖诱导的急性肺损伤的影响;⑤采用小鼠败血症生存实验评价聚腺苷二磷酸核糖聚合酶1抑制剂AG14361对小鼠急性肺损伤和生存时间的影响。
结果与结论:①活化的中性粒细胞中聚腺苷二磷酸核糖聚合酶1表达明显上调;②成功构建聚腺苷二磷酸核糖聚合酶1低表达中性粒细胞系;③与对照组相比,聚腺苷二磷酸核糖聚合酶1低表达不影响中性粒细胞极化,但显著抑制中性粒细胞迁移、活化与炎性因子表达,并下调中性粒细胞表面C-X-C趋化因子受体2和C-X-C趋化因子受体4的表达;④中性粒细胞过继转移实验证实特异性敲低中性粒细胞聚腺苷二磷酸核糖聚合酶1表达可减少肺组织中性粒细胞浸润,缓解脂多糖诱导的急性肺损伤;⑤聚腺苷二磷酸核糖聚合酶1抑制剂AG14361可减轻脂多糖诱导的急性肺损伤并延长败血症小鼠生存时间。结果表明,聚腺苷二磷酸核糖聚合酶1通过调控中性粒细胞C-X-C趋化因子受体2和C-X-C趋化因子受体4的表达影响中性粒细胞迁移和炎症效应功能,靶向抑制聚腺苷二磷酸核糖聚合酶1能够减少中性粒细胞肺组织浸润而缓解小鼠肺损伤,延长小鼠生存期。
http://orcid.org/0009-0003-3767-237X (高歌);http://orcid.org/0000-0001-6378-7486 (韩露露)


中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程

关键词: 急性肺损伤, 中性粒细胞, 炎症反应, 聚腺苷二磷酸核糖聚合酶1, 趋化因子受体

Abstract: BACKGROUND: In acute lung injury, the activation and tissue infiltration of neutrophils are key contributing factors. Inhibiting poly(ADP-ribose) polymerase 1 activity can reduce the number of infiltrating neutrophils in lung tissue following lipopolysaccharide treatment and alleviate lung injury. However, the specific mechanism by which poly(ADP-ribose) polymerase 1 regulates neutrophil activation and function has not been fully elucidated.
OBJECTIVE: To investigate the effect and mechanism of poly(ADP-ribose) polymerase 1 in regulating neutrophil activation on acute lung injury in mice.
METHODS: (1) Using the human promyelocytic leukemia cell line HL-60 as a basis, cells were induced to differentiate into neutrophil-like cells (dHL-60) with dimethyl sulfoxide. Lipopolysaccharide was used to stimulate dHL-60 to obtain activated neutrophils, and Western blot was used to detect poly(ADP-ribose) polymerase 1 expression in activated neutrophils. (2) A neutrophil cell line with low poly(ADP-ribose) polymerase 1 expression was prepared using shRNA targeting human poly(ADP-ribose) polymerase 1, and the knockdown efficiency of poly(ADP-ribose) polymerase 1 was verified by western blot. (3) Western blot and immunofluorescence assays were used to detect the effect of low poly(ADP-ribose) polymerase 1 expression on neutrophil polarization; cell migration assays were used to detect the effect on neutrophil migration; real-time quantitative PCR and flow cytometry were used to detect the effect on chemokine receptor expression; and reactive oxygen species, interleukin 1β, and neutrophil extracellular traps were used to assess the effect on neutrophil activity. (4) Primary mouse neutrophils with low poly(ADP-ribose) polymerase 1 expression were prepared using shRNA targeting mouse poly(ADP-ribose) polymerase 1. In a mouse neutrophil adoptive transfer model, the effect of low poly(ADP-ribose) polymerase 1 expression on lipopolysaccharide-induced acute lung injury was verified by assessing pulmonary edema, myeloperoxidase activity, and hematoxylin-eosin staining. (5) A mouse sepsis survival experiment was performed to evaluate the effect of the poly(ADP-ribose) polymerase 1 inhibitor AG14361 on acute lung injury and survival time in mice.
RESULTS AND CONCLUSION: (1) Poly(ADP-ribose) polymerase 1 expression was significantly upregulated in activated neutrophils. (2) A neutrophil cell line with low poly(ADP-ribose) polymerase 1 expression was successfully constructed. (3) Compared with the control group, low poly(ADP-ribose) polymerase 1 expression did not affect neutrophil polarization but significantly inhibited neutrophil migration, activation, and inflammatory factor expression. The expression of C-X-C chemokine receptor 2 and C-X-C chemokine receptor 4 on the neutrophil surface was significantly downregulated. (4) Neutrophil adoptive transfer experiments confirmed that specifically knocking down poly(ADP-ribose) polymerase 1 expression in neutrophils reduced neutrophil infiltration in lung tissue and alleviated lipopolysaccharide-induced acute lung injury. (5) The poly(ADP-ribose) polymerase 1 inhibitor AG14361 alleviated lipopolysaccharide-induced acute lung injury and prolonged the survival time of septic mice. Overall, these findings indicate that poly(ADP-ribose) polymerase 1 affects neutrophil migration and inflammatory effector functions by regulating the expression of C-X-C chemokine receptor 2 and C-X-C chemokine receptor 4. Targeted inhibition of poly(ADP-ribose) polymerase 1 can reduce neutrophil infiltration in lung tissue, thereby alleviating lung injury and prolonging survival in mice.

Key words: acute lung injury, neutrophil, inflammatory response, poly(ADP-ribose) polymerase 1, chemokine receptor

中图分类号: